Skip to main content

Advertisement

Log in

Early detection of cognitive impairment in patients with insulinoma

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Long-standing hypoglycemia can cause cognitive impairment, and whether recurrent severe hypoglycemia impacts cognitive function in patients with insulinoma has not been studied. This study focused on exploring the cognitive function in patients with insulinoma.

Methods

A prospective study was conducted to assess cognitive function in patients with insulinoma by administering the Montreal Cognitive Assessment (MoCA) questionnaire between January 2016 and July 2017, and patients with cognitive impairment were followed up to undergo the MoCA test 1 year after surgery. The MoCA scores after surgery were compared with the scores before surgery, and the associations between cognitive impairment and relevant factors were further evaluated by multiple linear regression analysis.

Results

Eighteen out of thirty-four patients (53%) with insulinoma were screened positive for cognitive impairment as defined by a MoCA score <26. Performance in certain cognitive domains, including visuospatial and executive functions, delayed memory, attention, language, and abstraction, was significantly worse in patients with cognitive impairment. Multivariate analysis indicated that MoCA scores correlated significantly with tumor grade and years of education. Eight patients with cognitive impairment were lost to follow-up. The remaining ten patients with cognitive impairment showed improvements 1 year postoperatively, and seven patients recovered to normal cognitive function.

Conclusions

Cognitive impairment was found in patients with insulinoma and was reversible in some patients 1 year after surgery. More studies are needed to explore the underlying mechanisms of the existence and reversibility of cognitive impairment in patients with insulinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. F.J. Service, M.M. McMahon, P.C. O’Brien, D.J. Ballard, Functioning insulinoma–incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo. Clin. Proc. 66, 711–719 (1991)

    Article  CAS  PubMed  Google Scholar 

  2. D.C. Metz, R.T. Jensen, Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 135, 1469–1492 (2008)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. M.H. Kulke, L.B. Anthony, D.L. Bushnell, W.W. de Herder, S.J. Goldsmith, D.S. Klimstra, S.J. Marx, J.L. Pasieka, R.F. Pommier, J.C. Yao, R.T. Jensen, NANETS Treatment Guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 39, 735–752 (2010)

    Article  PubMed  PubMed Central  Google Scholar 

  4. W.W. De Herder, B. Niederle, J.Y. Scoazec, S. Pauwels, G. Kloppel, M. Falconi, D.J. Kwekkeboom, K. Oberg, B. Eriksson, B. Wiedenmann, G. Rindi, D. O’Toole, D. Ferone, Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 84, 183–188 (2006)

    Article  CAS  PubMed  Google Scholar 

  5. M. Falconi, B. Eriksson, G. Kaltsas, D.K. Bartsch, J. Capdevila, M. Caplin, B. Kos-Kudla, D. Kwekkeboom, G. Rindi, G. Klöppel, N. Reed, R. Kianmanesh, R.T. Jensen; Vienna Consensus Conference participants., ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103, 153–171 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Y. Ding, S. Wang, J. Liu, Y. Yang, Z. Liu, J. Li, B. Zhang, Y. Chen, M. Ding, Neuropsychiatric profiles of patients with insulinomas. Eur. Neurol. 63, 48–51 (2010)

    Article  PubMed  Google Scholar 

  7. R.E. Warren, B.M. Frier, Hypoglycaemia and cognitive function. Diabetes Obes. Metab. 7, 493–503 (2005)

    Article  PubMed  Google Scholar 

  8. B.A. Kirchhoff, H.M. Lugar, S.E. Smith, E.J. Meyer, D.C. Perantie, B.C. Kolody, J.M. Koller, A.M. Arbelaez, J.S. Shimony, T. Hershey, Hypoglycemia-induced changes in regional brain volume and memory function. Diabet. Med. 30, 151–156 (2013)

    Article  Google Scholar 

  9. T. Hershey, D.C. Perantie, S.L. Warren, E.C. Zimmerman, M. Sadler, N.H. White, Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care 28, 2372–2377 (2005)

    Article  PubMed  Google Scholar 

  10. S.A. Ebadi, P. Darvish, A.J. Fard, B.S. Lima, O.G. Ahangar, Hypoglycemia and cognitive function in diabetic patients. Diabetes Metab. Syndr. 12, 893–896 (2018)

    Article  PubMed  Google Scholar 

  11. G. Pozzessere, E. Valle, C. D’Alessio, G. Soldati, F. Pierelli, F. Leonetti, M. Foniciello, G. Tamburrano, Effects of spontaneous chronic hypoglycemia on central and peripheral nervous system in insulinoma patients before and after surgery: a neurophysiological follow-up. J. Clin. Endocrinol. Metab. 82, 1447–1451 (1997)

    Article  CAS  PubMed  Google Scholar 

  12. Z.S. Nasreddine, N.A. Phillips, V. Bédirian, S. Charbonneau, V. Whitehead, I. Collin, J.L. Cummings, H. Chertkow, The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 53, 695–699 (2005)

    Article  PubMed  Google Scholar 

  13. V. Hachinski, C. Iadecola, R.C. Petersen, M.M. Breteler, D.L. Nyenhuis, S.E. Black, W.J. Powers, C. DeCarli, J.G. Merino, R.N. Kalaria, H.V. Vinters, D.M. Holtzman, G.A. Rosenberg, A. Wallin, M. Dichgans, J.R. Marler, G.G. Leblanc, National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37, 2220–2241 (2006)

    Article  PubMed  Google Scholar 

  14. K. Alagiakrishnan, N. Zhao, L. Mereu, P. Senior, A. Senthilselvan, Montreal Cognitive Assessment is superior to standardized Mini-Mental Status Exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed. Res. Int. 2013, 186106 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  15. S.H. Mohun, M.B. Spitznagel, J. Gunstad, A. Rochette, L.J. Heinberg, Performance on the Montreal Cognitive Assessment (MoCA) in older adults presenting for bariatric surgery. Obes. Surg. 28, 2700–2704 (2018)

    Article  PubMed  Google Scholar 

  16. C. Frengopoulos, M.W. Payne, R. Viana, S.W. Hunter, MoCA domain score analysis and relation to mobility outcomes in dysvascular lower extremity amputees. Arch. Phys. Med. Rehabil. 99(2), 314–320 (2018)

    Article  PubMed  Google Scholar 

  17. S. Shaefi, E.R. Marcantonio, A. Mueller, V. Banner-Goodspeed, S.C. Robson, K. Spear, L.E. Otterbein, B.P. O’Gara, D.S. Talmor, B. Subramaniam, Intraoperative oxygen concentration and neurocognition after cardiac surgery: study protocol for a randomized controlled trial. Trials 18, 600 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  18. H. Dai, Q. Xu, X. Hong, X. Wang, H. Pang, W. Wu, Y. Zhao, Surgery in overweight patients with insulinoma: effects on weight loss. Scand. J. Gastroenterol. 52, 1037–1041 (2017)

    PubMed  Google Scholar 

  19. F. Tian, X.F. Hong, W.M. Wu, X.L. Han, M.Y. Wang, L. Cong, M.H. Dai, Q. Liao, T.P. Zhang, Y.P. Zhao, Propensity score-matched analysis of robotic versus open surgical enucleation for small pancreatic neuroendocrine tumours. Br. J. Surg. 103, 1358–1364 (2016)

    Article  CAS  PubMed  Google Scholar 

  20. R.V. Lloyd, R.Y. Osamura, G. Klöppel, J. Rosai, in WHO Classification of Tumours of Endocrine Organs, 4th edn. (International Agency for Research on Cancer (IARC), Lyon, 2017).

  21. O.N. Tucker, P.L. Crotty, K.C. Conlon, The management of insulinoma. Br. J. Surg. 293, 264–275 (2006)

    Article  Google Scholar 

  22. R.M. Crum, J.C. Anthony, S.S. Bassett, M.F. Folstein, Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269, 2386–2391 (1993)

    Article  CAS  PubMed  Google Scholar 

  23. S. Hoops, S. Nazem, A.D. Siderowf, J.E. Duda, S.X. Xie, M.B. Stern, D. Weintraub, Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73, 1738–1745 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. C. DeCarli, Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2, 15–21 (2003)

    Article  PubMed  Google Scholar 

  25. E.C. Puente, J. Silverstein, A.J. Bree, D.R. Musikantow, D.F. Wozniak, S. Maloney, D. Daphna-Iken, S.J. Fisher, Recurrent moderate hypoglycemia ameliorates brain damage and cognitivedysfunction induced by severe hypoglycemia. Diabetes 59, 1055–1062 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. A.J. Sommerfield, I.J. Deary, V. McAulay, B.M. Frier, Short-term, delayed and working memory are impaired during hypoglycemia in individuals with type 1 DM. Diabetes Care 26, 390–396 (2003)

    Article  PubMed  Google Scholar 

  27. I. Feinkohl, P.P. Aung, M. Keller, C.M. Robertson, J.R. Morling, S. McLachlan, I.J. Deary, B.M. Frier, M.W. Strachan, J.F. Price, Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: The Edinburgh type 2 diabetes study. Diabetes Care 37, 507–515 (2014)

    Article  CAS  Google Scholar 

  28. Y.X. Chen, Z.R. Liu, Y. Yu, E.S. Yao, X.H. Liu, L. Liu, Effect of recurrent severe hypoglycemia on cognitive performance in adult patients with diabetes: a meta-analysis. J. Huazhong Univ. Sci. Technol. Med. Sci. 37, 642–648 (2017).

    PubMed  Google Scholar 

  29. A. Couvelard. Pathological evaluation and classification of digestive neuroendocrine tumours. Neuroendocrine tumours: diagnosis and management. S. Yalcin, K. Öberg (eds) (SpringerVerlag, Berlin–Heidelberg), 2015, 59–76

  30. F. Grillo, M. Albertelli, F. Annunziata, M. Boschetti, A. Caff, S. Pigozzi, D. Ferone, L. Mastracci, Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? Endocrine 53, 58–62 (2016)

    Article  CAS  PubMed  Google Scholar 

  31. P. Wolf, Y. Winhofer, S. Smajis, C.H. Anderwald, C. Scheuba, B. Niederle, A. Gessl, A. Luger, M. Krebs, O. Koperek, Clinical presentation in insulinoma predicts histopathological tumour characteristics. Clin. Endocrinol. 83, 67–71 (2015)

    Article  CAS  Google Scholar 

  32. C. Iadecola, Hypertension and dementia. Hypertension 64, 3–5 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81573009, 81773292, 81603157) and Chinese Academy of Medical Sciences Initiative for Innovative Medicine (CAMS-I2M 2017-I2M-1-001).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yupei Zhao or Wenming Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study protocol (S-K654) was approved by the Institutional Ethics Committee of PUMCH, Chinese Academy of Medical Sciences.

Informed consent

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dai, H., Chen, H., Hong, X. et al. Early detection of cognitive impairment in patients with insulinoma. Endocrine 65, 524–530 (2019). https://doi.org/10.1007/s12020-019-01994-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-01994-x

Keywords

Navigation